Erik Skullerud
Plus aucun poste en cours
Fortune : 355 $ au 31/03/2024
Profil
Erik Skullerud was the founder and had founded Element Consulting GmbH in 2017, where he held the title of Managing Partner.
He also held former positions as Chief Executive Officer at Nordic Nanovector ASA from 2021 to 2022, Marketing Director at Amgen AB from 2004 to 2016, and Group Product Manager at Bayer Pharma AG from 1997 to 2000.
Mr. Skullerud's education history includes undergraduate degrees from Concordia University and Handelshögskolan i Göteborg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
THOR MEDICAL ASA
0,00% | 31/12/2022 | 3 571 ( 0,00% ) | 355 $ | 31/03/2024 |
Anciens postes connus de Erik Skullerud
| Sociétés | Poste | Fin |
|---|---|---|
| THOR MEDICAL | Chief Executive Officer | 26/08/2022 |
Amgen AB
 Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Sales & Marketing | 01/05/2016 |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Corporate Officer/Principal | 01/05/2000 |
| Element Consulting GmbH | Founder | - |
Formation de Erik Skullerud
| Concordia University | Undergraduate Degree |
| Handelshögskolan i Göteborg | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
Amgen AB
Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
| Element Consulting GmbH |
